An eosinophil-rich ANCA-associated vasculitis; anti-IL-5 therapy reduces relapses and steroid burden.
An ANCA-associated vasculitis; remission induction and maintenance combine immunosuppression with newer targeted agents.
Sign in to your account
Remember me
